Clinical Trial Update: A Study of Two Different Formulations of 611 in Healthy Adult Subjects in China [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating two formulations of 611 in healthy adult subjects in China; Atopic Dermatitis is listed as the condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• 611 (Formulation A) (611)
• 611 (Formulation B) (611)

Snippet

Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Conditions: Atopic Dermatitis | Phase 1 | Status: NOT_YET_RECRUITING